Skip to main content

Blood Glucose Testing Regime?

Can anyone advise on where my logic falls down? It must do, but this has been playing on my mind for a while. The basic question is...why would someone on MDI need to test 5-8-10+ times a day? I can feel people's heckles being raised already, but keep reading.

I'm T1 on MDI, Levemir (split dose) and Novorapid (peak action 1-3 hours, tail of action 3-5 hours). Clearly, testing regimes must be very different if you're on a pump.

Have a look at the table below showing a typical 'Nick Day'. OK, I don't eat lunch, both because I like the nice flat line I get on my Libre (hence better A1C, I hope) and I've found I don't need it.

If you look at the table, I've only managed to find five times where I think it could be worthwhile to check levels - in time, I think one of the morning ones could go too, so in reality four. At all other times, it seems pointless to me as either nothing should have changed (perhaps the 'should' is the key here) and/or the insulin is still working, so you can't really know what's going to happen and adding more insulin could be a bad thing and cause levels to 'roller-coaster'.

It's ringing in my ears that an eminent diabetologist is saying that a good A1C without testing more than 4 times a day is very difficult indeed. I don't understand why.

Where else would people test where I don't? Is it just because I don't eat lunch, don't drive much and don't particularly keep fit (and am not female, as has been suggested) that my testing regime can be simpler?  I do exercise, but don't play sport or go to a gym.

I'm sure books will explain this further, but would like some views.

Comments

Popular posts from this blog

Big Announcement - Libre Funding

NEWS RELEASE Embargoed 00:01 November 14 NHS TO PROVIDE LIFE CHANGING GLUCOSE MONITORS FOR TYPE 1 DIABETES PATIENTS Tens of thousands of people with Type 1 diabetes across the country will benefit from life changing glucose monitors on the NHS. To coincide with World Diabetes Day, Simon Stevens, Chief Executive of NHS England, is announcing action to end the current variation patients in some parts of the country are facing to access Freestyle Libre. The wearable sensor does away with the need for inconvenient and sometimes painful finger prick blood tests by relaying glucose levels to a smart phone or e-reader. NHS England will ensure the device, which is the size of a £2 coin and sits on the arm, is available on prescription for all patients who qualify for it in line with NHS clinical guidelines. From April 2019, these patients will be able to receive it on prescription from their local GP or diabetes team helping them to better manage their blood sugar levels. It comes as the NHS seeks t…

Libre - March 2018 Update

Since November 2017 and the official listing of Libre on prescription, so much has changed, but has it changed for the better?

I think broadly the answer to that question is No, but not for want of trying.  The situation has become increasingly confusing and disjointed.

Getting it on Prescription Firstly, the prescribing of Libre.  Wales have said yes, most other areas have said perhaps.  This map shows the current status by CCG: Diabetes UK Joint Policy Tracker.  There are improvements, but this demonstrates the postcode lottery.

The data on prescribing rates are published but this data is woefully slow to become in the public domain.  The final UK country to publish data was Scotland, which finally released December data on 13th March!

Here's the data so far:

This shows an increase, but hardly an avalanche!  Wish I could see the January data...Northern Ireland should publish very soon though.

There are CCGs like Manchester that have now approved prescribing, but it's slow an…

August Libre Update - Data, data and more data!

This month's update will be dealt with in two parts, both focusing on data; the first part summarising some data about the prescribing policies across England, the second my usual update on prescriptions fulfilled across the UK.
Libre Prescribing Policies and Implementation in England There didn't seem to be an easy way to compile this.  I used the Diabetes UK Map to link to the policies and then I cross-checked this with a Google search to see whether there was any more information.  I had to do this line by line for each of the 195 CCGs in England - quite a lengthy and tedious process.  However, I am pleased with the information arising from the data.

Firstly, the headline figures - how many CCGs were funding Libre, how many had denied funding and who were still undecided?  There are differences of opinion about these figures as some CCGs have not been clear (Staffordshire CCGs), and some have agreed to fund, but are yet to actually fund due to implementation difficulties (L…